NCT07272811 · RECRUITING

Neurocognitive Assessment Platform 4 Alzheimer

This study is building a digital tool to spot amnestic mild cognitive impairment, a stage between normal aging and dementia, earlier. It uses EEG, blood flow sensors and eye-tracking to measure brain and behavior signals in 100 adults aged 55 to 80 over 12 months. No drug or treatment is being tested. No phase is listed.

Eligibility criteria

Inclusion criteria common to both experimental groups:
* Signature of informed consent
* Age between 55 and 80 years
* Absence of functional impact on daily living activities or minimal impact on instrumental activities
Specfic inclusion criteria for Healthy Controls recruitment:
* Normal global cognitive efficiency (Mini Mental State Examination scores of 28 or higher)
* Absence of specific cognitive deficits (memory and other cognitive domains) that are abnormal for age, sex, and education level (1.5 standard deviations below the mean for age- and education-matched controls), as assessed by objective, standardized cognitive tests.
Specific inclusion criteria for aMCI recruitment:
* Cognitive difficulties reported by the individual, their family member, or their primary care physician
* Normal global cognitive efficiency (Mini Mental State Examination score within 0.5 standard deviations of the average for age- and education-matched control subjects).
* Specific cognitive deficits related to memory or multi-domain cognitive impairments (involving memory and other cognitive domains) that are atypical for the individual's age (1.5 standard deviations below the average for age- and education-matched controls), as determined by objective, standardized cognitive tests.
Exclusion Criteria:
* Rejection of informed consent
* Important sensory deficits (e.g., hearing loss or hypovisus)
* Current or previous history of psychiatric illness
* Current or previous degenerative pathology of the central nervous system (CNS)
* Presence of systemic diseases in anamnesis
* Presence of cerebrovascular events in anamnesis
* Use of alcohol or psychotropic substances in anamnesis

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-01-22

View full record on ClinicalTrials.gov

All APOE4 clinical trials